Rekvina Laboratories Share Price
05 Nov, 2026 4:01 PM (IST)
Rekvina Laboratories Performance
- Today's Low
- ₹58
- Today's High
- ₹60
- 52 Week Low
- ₹7
- 52 Week High
- ₹65
- Open Price₹60
- Previous Close₹57
- Volume1,897
- 50 DMA₹52.80
- 100 DMA₹46.80
- 200 DMA₹37.80
Rekvina Laboratories Chart
Investment Returns
- Over 1 Month + 16.59%
- Over 3 Month + 130.22%
- Over 6 Month + 36.97%
- Over 1 Year + 1191.78%
Smart Investing Starts Here Start SIP with Rekvina Laboratories for Steady Growth!
Rekvina Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -103.1
- PEG Ratio
- 1
- Market Cap Cr
- 35
- P/B Ratio
- -26
- Average True Range
- 3.4
- EPS
- -0.6
- Dividend Yield
- 0
- MACD Signal
- 1
- RSI
- 54.74
- MFI
- 33.19
Latest Stock News Updates
Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Financial Result for QTR2
- BSE India
- 2 days 16 hours ago
Intimation regarding Temporary Shutdown of Manufacturing Facility for Renovation, Upgradation and Installation of an Additional Vial Manufacturing Line.
- BSE India
- 1 week 2 days ago
Compliance Certifcate
- BSE India
- 3 weeks ago
Rekvina Laboratories Financials
Rekvina Laboratories Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹56.60
- 50 Day
- ₹52.80
- 100 Day
- ₹46.80
- 200 Day
- ₹37.80
Resistance and Support
- R3 61.00
- R2 60.40
- R1 59.30
- S1 57.60
- S2 57.00
- S3 55.90
Rekvina Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-13 | Quarterly Results | |
| 2026-08-13 | Quarterly Results | |
| 2026-05-21 | Audited Results | |
| 2026-03-16 | Preferential Issue of shares | Inter-alia, to consider 1.Proposal for issuance equity shares/any other securities of the Company, by way of Preferential issue, in accordance with provisions of Securities & Exchange Board of India. |
| 2026-02-06 | Quarterly Results |
About Rekvina Laboratories
Rekvina Labs engaged in providing comprehensive diagnostic and testing services, including clinical pathology, biochemistry, microbiology, molecular diagnostics, and advanced imaging. The company operates with a commitment to accuracy, reliability, and innovation in medical testing, supported by state-of-the-art laboratory technology and a team of highly skilled professionals. By upholding the highest standards of quality and precision and plays a vital role in disease detection, prevention, and treatment support, serving hospitals, clinics, and individual patients with trusted diagnostic solutions. View More- NSE Symbol
- VINRKLB
- BSE Symbol
- 526075
- ISIN
- INE092O01028
Similar Stocks to Rekvina Laboratories
Popular Stocks
Rekvina Laboratories FAQs
Rekvina Laboratories share price is ₹58 As on 06 November, 2026 | 04:36
The Market Cap of Rekvina Laboratories is ₹35 Cr As on 06 November, 2026 | 04:36
The P/E ratio of Rekvina Laboratories is -103.1 As on 06 November, 2026 | 04:36
The PB ratio of Rekvina Laboratories is -26 As on 06 November, 2026 | 04:36
The 52 week High & Low of Rekvina Laboratories is ₹65.1/₹6.8 respectively As on 06 November, 2026 | 04:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.